We are live on
!
Find out more
FC
Fore Capital Portfolio holdings
AUM
$338M
Turnover
62.67%
1-Year Est. Return
10.07%
This Fund
S&P 500
This Quarter
Est. Return
-0.9%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$80.2M
(-27%)
Cap. Flow
-$68.7M
Cap. Flow
% of AUM
-32.1%
Top 10 Holdings %
Top 10 Hldgs %
68.11%
Holding
64
New
12
Increased
1
Reduced
4
Closed
20
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$1.45M |
| 2 |
Essent Group
ESNT
|
+$667K |
| 3 |
MGIC Investment
MTG
|
+$525K |
| 4 |
Precigen
PGEN
|
+$329K |
| 5 |
Bank of America Series L
BAC.PRL
|
+$250K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.04M |
| 2 |
IDIV
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
|
+$1.95M |
| 3 |
Sotera Health
SHC
|
+$1.29M |
| 4 |
iShares Silver Trust
SLV
|
+$1.11M |
| 5 |
Sanofi
SNY
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 98.12% |
| 2 | Technology | 0.84% |
| 3 | Financials | 0.51% |
| 4 | Healthcare | 0.37% |
| 5 | Communication Services | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
DELISTED
Piedmont Lithium
PLL
| – | – |
-15,000
| Closed | -$843K | – |
|
|
27
PUT
DELISTED
Piedmont Lithium
PLL
| – | – |
-15,000
| Closed | -$787K | – |
|
|
28
Sotera Health
SHC
$5.16B
| – | – |
-55,000
| Closed | -$1.29M | – |
|
|
29
iShares Silver Trust
SLV
$27.9B
| – | – |
-50,000
| Closed | -$1.11M | – |
|
|
30
CALL
Sanofi
SNY
$96.5B
| – | – |
-80,000
| Closed | -$4.01M | – |
|
|
31
Sanofi
SNY
$96.5B
| – | – |
-20,000
| Closed | -$1M | – |
|
32
CALL
Scorpio Tankers
STNG
$4.15B
| – | – |
-120,000
| Closed | -$1.54M | – |
|
33
Trilogy Metals
TMQ
$444M
| – | – |
-225,766
| Closed | -$373K | – |
|
34
Vistra
VST
$51.7B
| – | – |
-39,409
| Closed | -$897K | – |
|
35
Viatris
VTRS
$20.9B
| – | – |
-10,000
| Closed | -$135K | – |
|
36
CALL
Williams Companies
WMB
$84.7B
| – | – |
-300,000
| Closed | -$7.81M | – |
|
|
37
PUT
Williams Companies
WMB
$84.7B
| – | – |
-50,000
| Closed | -$1.3M | – |
|
38
T1 Energy
TE
$878M
| – | – |
-60,000
| Closed | -$575K | – |
|
|
IDIV
39
DELISTED
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
| – | – |
-191,605
| Closed | -$1.95M | – |
|
Similar funds
EWA
ECAM
1CM
NIWA
HFS
CWM
BAM
JWM
Fore Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Fore Capital held 64 positions worth $214M, down 27% from $294M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Fore Capital withdrew a net $68.7M in Q1 2022, closing 20 positions and reducing 4 holdings. Its most notable exit was AstraZeneca, an estimated $2.04M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, up from 96% a quarter earlier, followed by Technology and Financials.
Against the trend, Fore Capital opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $1.39M.
- Fore Capital's largest Q1 2022 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 1,050 shares worth $1.39M.
- Fore Capital's biggest Q1 2022 reduction was Clear Channel Outdoor Holdings, cutting an estimated $102K.
- Fore Capital fully exited AstraZeneca in Q1 2022, selling an estimated $2.04M.
- Fore Capital's ten largest holdings make up 68% of its $214M portfolio in Q1 2022.
- Fore Capital opened 12 new positions and closed 20 in Q1 2022.
- Fore Capital's portfolio value fell 27% quarter-over-quarter to $214M.
Based on Fore Capital's 13F filing for Q1 2022, filed 11 May 2022.